News

Oscient said that the employees affected by the restructuring will be offered severance benefits. The company is also eliminating approximately 25 positions which have been vacant. Following the

Forty-seven medical centers ordered the company’s Proxcelan seeds in the second quarter of fiscal 2009 compared to the 53 centers that ordered in the first quarter of fiscal

Loughlin was effective immediately. He will be responsible for establishing EH&S policies and standards, setting and tracking performance goals, and ensuring global consistency within the company’s EH&S and

For the second quarter of fiscal 2009, the company reported increased net revenue included product revenue of $8,061,000 for the second quarter of fiscal 2009, an 8.2% increase,

The decision was made based on the results of the Phase III study of maribavir in stem cell transplant patients, and the recommendation from the independent data monitoring

Mr Gallahue has successfully participated in a variety of financial transactions, including initial public offerings, mergers, joint ventures, private placements and follow-on offerings at a number of healthcare

Cardinal Health said that the new company will be named CareFusion, reflecting a diverse blend of medical technologies the company will offer to improve the safety and quality

Denver Health is receiving funding for the study as a team science award from the Colorado Clinical and Translational Sciences Institute. Accelr8 has provided analytical instrumentation to Denver

Monet1 is a Phase III study evaluating motesanib in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-squamous non-small cell lung cancer (NSCLC). Motesanib is